Promoting science to protect California from preventable diseases

Education Hour

Tuesday, December 11, 2018

Guest Speakers: Jennifer Sienko, MPH, Director, National HPV Roundtable, Communication and Public Engagement

Presentation may be downloaded for viewing here:

Recording of presentation

PDF of presentation slides

While vaccines to prevent Human Papillomavirus (HPV) infection have proven to be extremely effective both in protecting against HPV, as well as reducing the risk of cervical cancer caused by HPV strains, acceptance of this cancer-preventing vaccine has struggled to reach the same level of acceptance as other vaccines recommended at this age. Providers have a unique opportunity to address vaccine hesitancy and reinforce the decision to vaccinate.

Jennifer Sienko leads the HPV Roundtable work on HPV vaccine communication and public engagement through social media, and manages the digital footprint of both the HPV Roundtable and the newly-formed HPV Cancer Free Families Facebook group. Prior to her work with the National HPV Vaccination Roundtable, Jennifer was the special assistant to the President’s Cancer Panel where she helped research, write and pu blish several reports, including Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer . She received her MPH from The George Washington University.

Thursday, August 23, 2018

Guest Speakers: C. Mary Healy, MD and Rebeca Monteleagre Boyte, MAS

Presentation may be downloaded for viewing here:

Protecting Mothers and Infants

PDF of presentation slides

In the United States and other countries, maternal immunization is recommended to protect both mother and young infants from vaccine-preventable diseases. The rationale for maternal immunization is built on the concept of passive protection; women mount an antibody response after immunization and transfer protective antibodies across the placenta during pregnancy to protect the infant during the first months of life. Influenza and pertussis vaccination is recommended for all pregnant women in the United States.
On our August webinar Dr. Healy did a fantastic job discussing the rationale and evidence for these recommendations and strategies to improve vaccination rates in pregnant women and gave concrete examples for communicating with patients.  Rebeca Boyte from the California Department of Public Health gave an important update on resources and materials to help promote vaccinations for pregnant women in a clinic or practice setting, or community settings such as pharmacy’s.

C. Mary Healy, M.D. is a Pediatric Infectious Disease Specialist with Texas Children’s Hospital and Associate Professor of Pediatrics at Baylor College of Medicine, Houston, Texas. She received her medical degree from the National University of Ireland and completed pediatric residency and fellowship training in Ireland. She also completed fellowships in pediatric infectious diseases, and in Vaccinology and Vaccine-Preventable Diseases at Baylor College of Medicine, where she has served on faculty there since 2005.  She serves on the a number of working groups for the Advisory Committee on Immunization Practices, Centers for Disease Control and

Wednesday, April 4, 2018 – 12:00 noon PT

Guest Speaker: Mark Sawyer, MD, FAAP

Presentation may be downloaded here:  Shingles 2.0: What You Need To Know – April 4, 2018

PDF of presentation: Slides

Did you know that 1 in 3 adults will get shingles in their lifetime, but less than 30% of older adults get vaccinated? Join the California Immunization Coalition Education Hour to learn more about Herpes Zoster disease and epidemiology, new ACIP recommendations for vaccination, and messaging about the new Shingrix vaccine. Join us today at noon (PT) for updates on the new vaccine to protect those at risk for this disease.

Moderated by Meg Dorsey, RN, PHN and featuring guest speaker,  Mark Sawyer, MD, FAAP


  • Explain the clinical benefits and recommendations for administration of Shingrix, the new shingles vaccine
  • Explain the differences between Shingrix and Zostavax vaccines
  • Create and/or implement effective messaging to staff and patients on the benefits of the new shingles vaccine

Tuesday, December 5, 2017 – 12:00 noon PT

View the Archived Presentation

Our most webinar focused on the current Hepatitis A outbreaks in California and strategies for response and prevention.

  • Describe Hepatitis A modes of transmission, morbidity and mortality
  • Describe the unique characteristics of the current California outbreak
  • Identify strategies that California counties have employed in response to this outbreak
  • Identify strategies to increase Hep A vaccination
Featured Presenters: 
Sayone Thihalolipavan, MD, MPH
Deputy Public Health Officer Public Health Services,

County of San Diego Health & Human Services Agency

Sharon Balter, MD
Director, Acute Communicable Disease Control Program
Los Angeles County Department of Public Health

Close Menu